J&J pulls out of NYC biotech incubator as it shrinks locationsnews2026-03-17T11:00:29+00:00March 17th, 2026|Endpoints News|
Federal judge halts CDC’s childhood vaccine overhaul news2026-03-16T20:37:18+00:00March 16th, 2026|Endpoints News|
BioMarin halts Phase 2 Voxzogo dosing in certain patients over safety concernnews2026-03-16T18:55:04+00:00March 16th, 2026|Endpoints News|
Roivant CEO, bullish on internal growth, dodges M&A chatternews2026-03-13T19:12:27+00:00March 13th, 2026|Endpoints News|
Pfizer to close Ignite, its R&D services unit for small biotechsnews2026-03-12T16:22:55+00:00March 12th, 2026|Endpoints News|
Lilly warns of impurity risk in certain compounded forms of Mounjaro and Zepboundnews2026-03-12T10:53:16+00:00March 12th, 2026|Endpoints News|
Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sanknews2026-03-12T07:00:56+00:00March 12th, 2026|Endpoints News|
Evotec plans up to 800 job cuts, four site closuresnews2026-03-11T19:44:46+00:00March 11th, 2026|Endpoints News|
FDA merges adverse event trackers into one databasenews2026-03-11T19:44:22+00:00March 11th, 2026|Endpoints News|
Eli Lilly CEO David Ricks seeks ‘exit velocity’ for pharma’s futurenews2026-03-11T14:37:56+00:00March 11th, 2026|Endpoints News|
